BTG Specialty Pharmaceuticals - Ownership and Business Overview

Medical ProductsCompany

BTG Specialty Pharmaceuticals Ownership

Who owns BTG Specialty Pharmaceuticals?

BTG Specialty Pharmaceuticals is owned by SERB S.a.r.l.. It was acquired on December 1, 2020.

BTG Specialty Pharmaceuticals Business Overview

Where is BTG Specialty Pharmaceuticals headquartered?

BTG Specialty Pharmaceuticals is headquartered in Gladwyne, Pennsylvania.

What sector is BTG Specialty Pharmaceuticals in?

BTG Specialty Pharmaceuticals is a medical products company.

Medical Products M&A Summary in 2020

Out of 60 sectors in the Mergr database, medical products ranked 12 in number of deals in 2020. The largest medical products acquisition in 2020 was Livongo Health - which was acquired by Teladoc Health for $18.5B.

Join Mergr to view all 217 acquisitions of medical products companies in 2020, including 32 acquisitions by private equity firms, and 185 by strategics.

BTG Specialty Pharmaceuticals

300 Four Falls Corporate Center, Suite 300,
Gladwyne, Pennsylvania 19035
United States,
(844) 293 0007
www.btgsp.com

BTG Specialty Pharmaceuticals develops, manufactures, and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.